23 Dec 2024: record year for AI trials
In 2024, artificial intelligence (AI) continued to be shown as an invaluable tool with the potential to accelerate clinical trials and improve patient care and outcomes. AI has already proven its ability to identify and prioritise novel disease targets and aid in the discovery of novel drugs. Now, AI’s applications are being extended to include the management of clinical trials.
One major way AI is set to revolutionise clinical trials is by automating patient recruitment, which is typically the most time-consuming part of a clinical trial. AI is being utilised to find matching candidates in patient databases. Additionally, several large pharma companies such as Roche and AstraZeneca are already utilising large language models to generate optimized eligibility criteria. Read more…